We are live on ! Find out more
RKDA icon

Arcadia Biosciences

24 hedge funds and large institutions have $39.6M invested in Arcadia Biosciences in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+24
Holders Change %
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
26
Citigroup
New York
$1K
Morgan Stanley
27
Morgan Stanley
New York
$1K

RKDA Hedge Fund Activity: Q2 2015 in Review

24 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q2 2015, worth a combined $39.6M.

Buyers outnumbered sellers: 24 funds opened new RKDA positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $42.2M.

  • 24 institutional investors held Arcadia Biosciences (RKDA) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $39.6M of Arcadia Biosciences stock for Q2 2015.
  • 24 funds opened new Arcadia Biosciences positions in Q2 2015 and 0 closed out, a net change of +24 holders.
  • The largest Arcadia Biosciences buyer in Q2 2015 was Waddell & Reed Financial, an estimated $42.2M added.

Based on aggregated 13F filings for Q2 2015.